Gastroesophageal reflux disease (GERD) affects an estimated 1.03 billion people worldwide, with prevalence ranging significantly by region. Defined as a condition where stomach contents reflux causes troublesome symptoms like heartburn and regurgitation, GERD’s diagnosis often involves endoscopy and reflux monitoring, especially for patients unresponsive to initial treatments. Advanced diagnostic tools such as pH or impedance-pH monitoring and high-resolution esophageal manometry help clinicians confirm GERD and assess for surgical suitability in more severe cases. Evolving treatments include tailored use of proton pump inhibitors (PPIs), novel medical therapies, and endoscopic procedures. Explore the full article for a comprehensive review of diagnostic and management strategies that are helping clinicians better address this pervasive condition.
Trending
- EndoQuest Robotics Announces Completion of Enrollment in the PARADIGM Trial (Business Wire)
- A single blood sample may improve the prediction of colorectal cancer recurrence or metastasis, kaist study finds (EurekAlert)
- At-Home Colorectal Cancer Tests Are Not a One-and-Done Deal (Cancer Health)
- How AI clears the way for colonoscopy screening (American Medical Association)
- Inside Diverticulitis: What Gastroenterologists Need to Know (Medscape)
- Abbott reports diagnostics growth since $21B Exact Sciences buy (Medtech Dive)
- Video Capsule Endoscopy Has Widening Role Beyond Diagnosis of Small-Bowel Bleeding (GI & Endoscopy News)
- How the AGA Incubator is shaping the future of digestive health (AGA)
